 | Up a level |
Reichen, Juerg (2010). ACP Journal Club. Telaprevir combination therapy induced a sustained virologic response in nonresponsive chronic HCV infection. Annals of internal medicine, 153(4), JC2-7. Philadelphia, Pa.: American College of Physicians 10.1059/0003-4819-153-4-201008170-02007
Bruegger, Lukas; Studer, Peter; Schmid, Stefan W; Pestel, Gunther; Reichen, Juerg; Seiler, Christian; Candinas, Daniel; Inderbitzin, Daniel (2008). Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation. Journal of gastrointestinal surgery, 12(1), pp. 67-72. New York, N.Y.: Springer-Verlag 10.1007/s11605-007-0352-3
Veldt, Bart J; Chen, Wendong; Heathcote, E Jenny; Wedemeyer, Heiner; Reichen, Juerg; Hofmann, W Peter; de Knegt, Robert J; Zeuzem, Stefan; Manns, Michael P; Hansen, Bettina E; Schalm, Solko W; Janssen, Harry L A (2008). Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology, 47(6), pp. 1856-62. Hoboken, N.J.: Wiley Interscience 10.1002/hep.22251
Reichen, Juerg (2008). Review: ursodeoxycholic acid does not reduce risk for mortality or liver transplantation in primary biliary cirrhosis. ACP journal club, 148(1), p. 17. Philadelphia, Pa.: American College of Physicians
Schweiger, Alexander; Ammann, Rudolf W; Candinas, Daniel; Clavien, Pierre-Alain; Eckert, Johannes; Gottstein, Bruno; Halkic, Nerman; Muellhaupt, Beat; Prinz, Bettina Mareike; Reichen, Juerg; Tarr, Philip E; Torgerson, Paul R; Deplazes, Peter (2007). Human alveolar echinococcosis after fox population increase, Switzerland. Emerging infectious diseases, 13(6), pp. 878-882. Atlanta, Ga.: U.S. National Center for Infectious Diseases
Veldt, Bart J; Heathcote, E Jenny; Wedemeyer, Heiner; Reichen, Juerg; Hofmann, W Peter; Zeuzem, Stefan; Manns, Michael P; Hansen, Bettina E; Schalm, Solko W; Janssen, Harry L A (2007). Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Annals of internal medicine, 147(10), pp. 677-84. Philadelphia, Pa.: American College of Physicians
Reichen, Juerg (2006). Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for non-alcoholic fatty liver disease. Evidence-based medicine, 11(1), p. 26. Philadelphia, Pa.: American College of Physicians
Neef, Markus; Ledermann, Monika; Saegesser, Hans; Schneider, Vreni; Reichen, Juerg (2006). Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. Journal of hepatology, 45(6), pp. 786-96. Amsterdam: Elsevier 10.1016/j.jhep.2006.07.030
Shaw, Sidney G; Boden, Jane P; Biecker, Erwin; Reichen, Juerg; Rothen, Barbara (2006). Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin. Experimental biology and medicine, 231(6), pp. 1101-5. Maywood, N.J.: Society for Experimental Biology & Medicine
Reichen, Juerg (2006). Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for nonalcoholic fatty liver disease. ACP journal club, 144(1), p. 22. Philadelphia, Pa.: American College of Physicians
Neef, Markus; Ledermann, Monika; Saegesser, Hans; Schneider, Vreni; Widmer, Nicolas; Decosterd, Laurent Arthur; Rochat, Bertrand; Reichen, Juerg (2006). Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term. Journal of hepatology, 44(1), pp. 167-75. Amsterdam: Elsevier 10.1016/j.jhep.2005.06.015
